← FDA DRUG APPROVALS

FDA ANDA · ANDA073532

POTASSIUM CHLORIDE

Sponsor: TEVA

APPLICATION
ANDA073532
TYPE
ANDA
ORIGINAL APPROVAL
1996-04-26
LATEST ACTION
1998-09-18
ROUTE
ORAL
DOSAGE FORM
CAPSULE, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

POTASSIUM CHLORIDEDiscontinued
POTASSIUM CHLORIDE 10MEQ · CAPSULE, EXTENDED RELEASE · ORAL

Approval history

1998-09-18Manufacturing (CMC) · Supplement 4AP
1997-12-10Manufacturing (CMC) · Supplement 3AP
1997-12-10Manufacturing (CMC) · Supplement 2AP
1997-06-18Manufacturing (CMC) · Supplement 1AP
1996-04-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →